5JA1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sprint Bioscience AB

Watchlist Manager

Watchlist

Price: 0.357 EUR 1.13% Market Closed

Market Cap: €24.9m

	Sprint Bioscience AB F:5JA1	SE
	Maxlinear Inc NASDAQ:MXL	US
S	SFL Corporation Ltd F:UG6	BM
	China Construction Bank Corp OTC:CICHF	CN
	Banco Santander SA MAD:SAN	ES
B	Bank Of Princeton NASDAQ:BPRN	US
	Anpario PLC F:KI9A	UK

Profitability Summary

Sprint Bioscience AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Negative 3Y Average Gross Margin

-1 386%

Gross Margin is Increasing

-15 956% > 92%

Exceptional Operating Margin

58%

Negative 3Y Average Operating Margin

-7 813%

Operating Margin is Increasing

-85 811% > 58%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-7 772%

Net Margin is Increasing

-85 364% > 55%

Exceptional Free Cash Flow Margin

50%

Negative 3Y Average Free Cash Flow Margin

-6 544%

Free Cash Flow Margin is Increasing

-71 910% > 50%

Exceptional ROE

143%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

ROIC is Increasing

-1 142% > 1 140%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.